Skip to Main Content

Paper Details

The impact of enzalutamide on quality of life in men with metastatic hormone-sensitive prostate cancer based on prior therapy, risk, and symptom subgroups.
Prostate
2
2022
Author NameAffiliation
Arnulf StenzlUniversity Hospital, Eberhard Karls University of Tubingen
Arun A Azad
  • 1 - 2

Datasets

Release 1.2